Evidence level: B
孟德尔随机化最怕的不是工具太少,而是工具”不纯”——同一个位点一边当”体质”的代言人,一边偷偷直接改结局,这种水平多效性一旦占比过高,连专门纠错的 MR-PRESSO 都会失灵。
正文
上一篇文章给九种体质的孟德尔随机化(MR)做了”强度审计”:结论是痰湿、阳虚、阴虚三质要先做到万人级 GWAS,凑出一批全基因组显著、LD 修剪后相互独立的工具变量(IV)。但”够强、够独立”只是入场券的一半——还有另一半更隐蔽:这些位点里,有多少是”一因多效”的?一个 SNP 同时影响体质、又绕过体质直接推高结局,叫水平多效性,它直接违反 MR 的排他性假设。本文就是那道”纯度审计”:在什么污染占比下,体质 MR 的结论开始不可信;痰湿体质——代谢疾病风险最高、也最可能富集代谢位点的体质——是不是天生就站在多效性的重灾区里。
MR-PRESSO 是怎么纠错的,它的能力边界在哪。 2018 年 Nature Genetics 上的 MR-PRESSO 方法学论文(PMID 29686387)做了三件事:全局检验(看整套工具变量是否存在多效性信号)、离群检验(揪出具体哪个 SNP 是”脏”的)、失真检验(把脏 SNP 剔除后重新估计因果效应,看结论翻没翻)。作者对 82 个复杂性状做了 4250 对因果检验,结果触目惊心:超过 48% 的显著因果关联存在可检测的水平多效性;多效性把因果估计扭曲了平均 −131% 到 +201%;还能在最多 10% 的关系里制造出假阳性。但它有一个写进方法学的硬边界:模拟显示,MR-PRESSO 只在”多效性工具占比低于 50%”时表现最好——一旦污染过半,它自己也扛不住。
这把”50%”的尺子,就是体质场景的裁决刻度。 现在把问题具体化:痰湿、阳虚、阴虚三质的万人级 GWAS 位点里,如果多效性工具占比只有 10%,MR-PRESSO 基本能全身而退,剔除离群点后因果估计接近无偏;占到 30%,纠错已经开始吃力,但配合 MR-Egger、加权中位数等敏感性分析仍可交叉验证;一旦到 50%,模拟给出的结论是纠错工具本身失去可靠性,此时任何”体质→结局”的因果效应量都只能算占位符。所以体质 MR 的”污染占比”裁决不是学术游戏——它决定一篇论文能不能写”因果”两个字。
痰湿体质为什么可能是多效性重灾区。 这不是猜测,而是两条已经发表的证据链叠出来的。第一条:痰湿体质与血脂基因的直接纠缠。2007 年的研究(PMID 17898945)用 PCR-RFLP 对比 61 名痰湿质与 48 名平和质,发现 LDL 受体基因(LDLR)的 Pvu II 与 Ava II 多态在痰湿质里显著富集(A+ 等位基因频率 0.3083 vs 0.1771,P+ 0.9098 vs 0.7708),而且痰湿质组的甘油三酯、空腹血糖、餐后血糖、餐后胰岛素全部显著更高。注意这里的关键:LDLR 是血脂代谢的核心基因,它的变异同时关联血脂水平和痰湿体质——这就是教科书级的”水平多效性”现场。第二条:痰湿体质本身被定义为一组代谢倾向。2013 年的基因组学综述(PMID 23548117)总结了痰湿体质上调 4 个基因(COPS8、GNPDA1、CD52、ARPC3)、下调 6 个基因(GSPT2、CACNB2 等),功能富集分析指向高脂血症与糖尿病易感性;流行病学数据也显示痰湿质人群肥胖、代谢综合征、高血压、糖尿病的风险远高于平和质。当”体质的遗传信号”与”代谢病的遗传信号”高度重叠时,一个位点到底是”体质位点”还是”代谢位点”——或者说它同时是两者——就成了统计上几乎无法拆开的问题。
最典型的案例:FTO rs7193144。 韩国四象体质 GWAS(PMID 25888059)在 5490 人(发现 3810 + 验证 1680)里发现,肥胖风险变异 rs7193144 与少阴型(少食、体瘦、代谢偏保护)反向关联(OR=0.729,p=1.47×10⁻⁷),且校正 BMI 后信号依然存在。这个位点本身就是多效性的活标本:它的主功能是肥胖易感(FTO 是首个 GWAS 确认的肥胖基因),同时又被用来”定义”少阴体质。假如有人拿 rs7193144 当少阴体质的 IV 去跑”少阴→卒中”的 MR,那么它通过 BMI、脂质、血糖直接作用于卒中的那部分效应,会被错误地全部算到”少阴体质”头上——这正是 −131%~+201% 扭曲的微观机制。FTO 案例还揭示了一个更深的麻烦:体质位点往往是”共享位点”而非”专有位点”,这本身就提示多效性不是例外而是体质遗传学的常态。
那这个裁决具体怎么落地? 步骤很清晰:第一步,把痰湿/阳虚/阴虚三质的候选 IV 集分别与结局 GWAS(如卒中、冠心病、2 型糖尿病)做 MR-PRESSO 全局/离群/失真三检验,逐对记录多效性工具占比;第二步,用模拟数据标定”占比 10/30/50%”梯度下 MR-PRESSO 在体质场景的检出率与纠偏幅度,得出体质专属的污染容忍线;第三步,对痰湿体质做”代谢位点富集检验”——把体质位点与已知代谢 GWAS 位点做重叠分析,检验痰湿质是否系统性富集代谢相关多效性位点(对照 FTO 与 LDLR 两条已知线索)。若结论是”痰湿质位点天然多效、占比超 50%”,那体质 MR 在痰湿质上就要么改用多效性稳健方法(如 CAUSE、多变量 MR),要么干脆承认该体质暂时做不了因果推断,只能停在关联层面——这本身就是有价值的科学结论,因为它精确划出了”体质因果学”目前能走到哪。
证据与局限
已验证: MR-PRESSO 在多效性工具占比 <50% 时纠错最佳,>50% 时失效(PMID 29686387,模拟+4250 对实证);水平多效性在 MR 中普遍存在,48% 显著关联可检出、扭曲 −131%~+201%(PMID 29686387);LDLR 多态与痰湿体质及血脂血糖异常同时关联(PMID 17898945);FTO rs7193144 与少阴体质反向关联且独立于 BMI(PMID 25888059)。
部分验证: 痰湿体质基因组学提示高血脂/糖尿病易感基因表达谱(PMID 23548117),但尚未直接量化”体质位点∩代谢位点”的多效性占比;FTO 位点的多效性行为是推断而非直接测量。
待验证: ①三质万人级 GWAS 位点的多效性工具占比实测值(10/30/50% 梯度标定);②痰湿体质是否系统性富集代谢多效性位点(对照 FTO/LDLR 线索);③占比超 50% 时 CAUSE/多变量 MR 能否替代 MR-PRESSO 完成体质因果推断。
相关阅读
- 体质工具变量强度审计:九种体质要闯过孟德尔随机化的三道闸门
- 九种体质万人级 GWAS 的”IV 密度”裁决
- 体质作暴露:孟德尔随机化如何把”体质→疾病”从相关变成因果
- 痰湿体质的”太阴映射”因果链跨人群复现裁决
- 生物频率密码研究池子
证据等级: B
参考文献: PMID 29686387, PMID 17898945, PMID 23548117, PMID 25888059
免责说明:本文属传统知识与科学文献的整理、对照与研究设计讨论,仅供理解与参考,不构成医疗建议,不能替代专业诊断与治疗。文中涉及的效应量、频率区间与暴露结论多为研究报告层面的推断,个体情况差异很大;如有身体不适或健康疑虑,请就医并由专业医师判断。
Multifinality of Instrumental Variables and Contamination: How Much Noise Renders an Instrument Inappropriate for Causal Inference?
Evidence level: B
Mendelian randomization (MR) fears not a lack of instruments, but their “impurity”—when a single locus simultaneously serves as a proxy for constitution while covertly directly altering the outcome. If such horizontal pleiotropy constitutes an excessive proportion of the instruments, even MR-PRESSO, a dedicated correction tool, may fail.
Main Text
In the previous article, we conducted an “intensity audit” for Mendelian randomization (MR) across nine constitutions. The conclusion was that the three constitutions of phlegm-dampness, yang deficiency, and yin deficiency require genome-wide association studies (GWAS) with sample sizes of at least 10,000 to assemble a set of instrument variables (IVs) that are genome-wide significant, pruned for linkage disequilibrium (LD), and mutually independent. However, being “strong enough” and “independent enough” constitutes only half the requirement; the other half is more subtle: what proportion of these loci exhibit “one cause, multiple effects”? When a SNP influences constitution while simultaneously bypassing constitution to directly elevate the outcome, this is termed horizontal pleiotropy, which directly violates MR’s exclusion restriction assumption. This article serves as that “purity audit”: at what contamination threshold does the conclusion of constitution-based MR become unreliable; and whether the phlegm-dampness constitution, which carries the highest metabolic disease risk and is most likely to enrich metabolic loci, is inherently situated in a high-risk zone for pleiotropy.
How MR-PRESSO corrects errors and its capability boundaries. The methodological paper on MR-PRESSO published in Nature Genetics in 2018 (PMID 29686387) undertook three tasks: global testing (assessing whether the entire set of IVs exhibits pleiotropic signals), outlier detection (identifying specific SNPs that are “contaminated”), and distortion testing (re-estimating the causal effect after removing contaminated SNPs to observe if conclusions flip). The authors performed 4,250 causal tests across 82 complex traits, yielding startling results: over 48% of significant causal associations exhibited detectable horizontal pleiotropy; pleiotropy distorted causal estimates by an average of −131% to +201%; and it could generate false positives in up to 10% of relationships. However, there is a hard boundary embedded in the methodology: simulations indicate that MR-PRESSO performs optimally only when the proportion of pleiotropic instruments is below 50%—once contamination exceeds this threshold, even the tool itself becomes unreliable.
This “50%” metric serves as the adjudication scale for constitution scenarios. Now, let us concretize the problem: within the 10,000-person GWAS loci for phlegm-dampness, yang deficiency, and yin deficiency, if the proportion of pleiotropic instruments is only 10%, MR-PRESSO can largely withstand the issue, and causal estimates remain nearly unbiased after removing outliers; at 30%, correction becomes strenuous, yet cross-validation with sensitivity analyses such as MR-Egger and the weighted median remains feasible; once reaching 50%, simulations indicate that the correction tools themselves lose reliability, at which point any causal effect estimate of “constitution → outcome” should be regarded merely as a placeholder. Therefore, the “contamination proportion” adjudication for constitution-based MR is not an academic game—it determines whether a paper can legitimately bear the word “causality.”
Why phlegm-dampness constitution may be a high-risk zone for pleiotropy. This is not speculation but the convergence of two published evidence chains. First: the direct entanglement between phlegm-dampness constitution and lipid metabolism genes. A 2007 study (PMID 17898945) compared 61 individuals with phlegm-dampness constitution against 48 with a balanced constitution using PCR-RFLP. It found significant enrichment of polymorphisms in the LDL receptor gene (LDLR)—specifically Pvu II and Ava II—in the phlegm-dampness group (A+ allele frequency 0.3083 vs. 0.1771; P+ 0.9098 vs. 0.7708), with all phlegm-dampness groups showing significantly higher triglycerides, fasting glucose, postprandial glucose, and postprandial insulin. Note the critical point here: LDLR is a core gene in lipid metabolism, and its variants are associated with both lipid levels and phlegm-dampness constitution—this is a textbook case of “horizontal pleiotropy” in action. Second: phlegm-dampness constitution itself is defined as a set of metabolic tendencies. A 2013 genomic review (PMID 23548117) summarized that phlegm-dampness constitution upregulates 4 genes (COPS8, GNPDA1, CD52, ARPC3) and downregulates 6 genes (GSPT2, CACNB2, etc.), with functional enrichment analysis pointing to hyperlipidemia and diabetes susceptibility; epidemiological data also shows that phlegm-dampness individuals have significantly higher risks of obesity, metabolic syndrome, hypertension, and diabetes compared to balanced constitution individuals. When “genetic signals of constitution” heavily overlap with “genetic signals of metabolic disease,” the question becomes whether a locus is a “constitution locus” or a “metabolic locus”—or if it serves both simultaneously—which becomes statistically nearly impossible to disentangle.
The most typical case: FTO rs7193144. The Korean four-constitution GWAS (PMID 25888059) identified in a cohort of 5,490 individuals (3,810 discovery + 1,680 validation) that the obesity-risk variant rs7193144 shows a reverse association with the Shaoyin constitution (characterized by low appetite, lean body type, and metabolic protection) (OR=0.729, p=1.47×10⁻⁷), with the signal persisting even after adjusting for BMI. This locus itself is a living specimen of pleiotropy: its primary function is obesity susceptibility (FTO was the first GWAS-confirmed obesity gene), yet it is simultaneously used to “define” the Shaoyin constitution. If someone were to use rs7193144 as an IV for the Shaoyin constitution to run an MR test for “Shaoyin → stroke,” the portion of its effect acting on stroke via BMI, lipids, and glucose would be erroneously attributed entirely to “Shaoyin constitution”—this is precisely the micro-mechanism behind the −131%~+201% distortion. The FTO case also reveals a deeper complication: constitution loci are often “shared loci” rather than “exclusive loci,” which itself suggests that pleiotropy is not an exception but a norm in constitutional genetics.
How to implement this adjudication concretely. The steps are clear: First, perform MR-PRESSO global/outlier/distortion tests on candidate IV sets for phlegm-dampness/yang deficiency/yin deficiency constitutions against outcome GWAS (e.g., stroke, coronary heart disease, type 2 diabetes), recording the proportion of pleiotropic instruments for each pair; Second, use simulated data to calibrate detection rates and correction magnitudes of MR-PRESSO in constitution scenarios across “10%/30%/50%” contamination gradients, deriving a constitution-specific contamination tolerance threshold; Third, conduct a “metabolic locus enrichment test” for phlegm-dampness constitution—overlap analysis between constitution loci and known metabolic GWAS loci to test whether phlegm-dampness constitution systematically enriches pleiotropic loci related to metabolism (using FTO and LDLR as known clues). If the conclusion is that “phlegm-dampness loci are naturally pleiotropic with proportions exceeding 50%,” then constitution-based MR for phlegm-dampness must either adopt pleiotropy-robust methods (such as CAUSE or multivariable MR) or simply acknowledge that causal inference for this constitution is currently unfeasible, remaining at the association level—this itself constitutes a valuable scientific conclusion, as it precisely delineates where current “constitutional causality” can reach.
Evidence and Limitations
Verified: MR-PRESSO performs best correction when pleiotropic instrument proportion <50% and fails >50% (PMID 29686387, simulation + 4,250 empirical pairs); horizontal pleiotropy is prevalent in MR, with 48% of significant associations detectable and distorted by −131%~+201% (PMID 29686387); LDLR polymorphism associates with both phlegm-dampness constitution and lipid/glucose abnormalities (PMID 17898945); FTO rs7193144 shows reverse association with Shaoyin constitution independent of BMI (PMID 25888059).
Partially Verified: Genomic data for phlegm-dampness constitution suggests expression profiles of hyperlipidemia/diabetes susceptibility genes (PMID 23548117), but the pleiotropic proportion of “constitution loci ∩ metabolic loci” has not yet been directly quantified; pleiotropic behavior of the FTO locus is inferred rather than directly measured.
To Be Verified: ① Empirical values of pleiotropic instrument proportions for 10,000-person GWAS loci across the three constitutions (calibration at 10%/30%/50% gradients); ② Whether phlegm-dampness constitution systematically enriches metabolic pleiotropic loci (using FTO/LDLR clues as controls); ③ Whether CAUSE or multivariable MR can replace MR-PRESSO to complete constitution-based causal inference when proportions exceed 50%.
Related Reading
- Constitution Instrument Variable Strength Audit: Nine Constitutions Must Pass Three MR Gates
- Adjudication on “IV Density” of Ten-Thousand-Person GWAS for Nine Constitutions
- Constitution as Exposure: How Mendelian Randomization Transforms “Constitution → Disease” from Correlation to Causality
- Cross-System MR Replication Adjudication on “Taiyin Mapping” Causal Chain of Phlegm-Dampness Constitution
- Research Pool for Biological Frequency
Evidence Level: B
References: PMID 29686387, PMID 17898945, PMID 23548117, PMID 25888059
Disclaimer: This article compiles traditional knowledge and scientific literature for comparison and research-design discussion only. It is not medical advice and cannot replace professional diagnosis or treatment. Effect sizes, frequency ranges and exposure conclusions cited here are largely inferences at the research-report level, and individual circumstances vary widely. If you have any discomfort or health concerns, please consult a physician.
Leave a Reply